Fusion Pharmaceuticals Stock Number Of Employees
Fusion Pharmaceuticals fundamentals help investors to digest information that contributes to Fusion Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Fusion Stock. The fundamental analysis module provides a way to measure Fusion Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fusion Pharmaceuticals stock.
Fusion |
Fusion Pharmaceuticals Company Number Of Employees Analysis
Fusion Pharmaceuticals' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Fusion Pharmaceuticals Number Of Employees | 101 |
Most of Fusion Pharmaceuticals' fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fusion Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
CompetitionBased on the recorded statements, Fusion Pharmaceuticals is currently employing 101 people. This is 99.08% lower than that of the Biotechnology sector and 81.13% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.46% higher than that of the company.
Fusion Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fusion Pharmaceuticals' direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fusion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Fusion Pharmaceuticals by comparing valuation metrics of similar companies.Fusion Pharmaceuticals is currently under evaluation in number of employees category among its peers.
Fusion Fundamentals
Return On Equity | -0.47 | |||
Return On Asset | -0.23 | |||
Operating Margin | (54.04) % | |||
Current Valuation | 1.69 B | |||
Shares Outstanding | 85.06 M | |||
Shares Owned By Insiders | 0.46 % | |||
Shares Owned By Institutions | 86.80 % | |||
Number Of Shares Shorted | 3.06 M | |||
Price To Book | 8.13 X | |||
Price To Sales | 874.50 X | |||
Revenue | 2.07 M | |||
Gross Profit | (57.43 M) | |||
EBITDA | (97.89 M) | |||
Net Income | (94.9 M) | |||
Cash And Equivalents | 198.42 M | |||
Cash Per Share | 4.57 X | |||
Total Debt | 50.33 M | |||
Debt To Equity | 0.08 % | |||
Current Ratio | 17.89 X | |||
Book Value Per Share | 2.85 X | |||
Cash Flow From Operations | (81.8 M) | |||
Short Ratio | 6.22 X | |||
Earnings Per Share | (1.40) X | |||
Target Price | 21.14 | |||
Number Of Employees | 101 | |||
Beta | -0.69 | |||
Market Capitalization | 1.83 B | |||
Total Asset | 285.84 M | |||
Retained Earnings | (376.76 M) | |||
Working Capital | 227.18 M | |||
Net Asset | 285.84 M |
Pair Trading with Fusion Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fusion Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fusion Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to GE Aerospace could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GE Aerospace when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GE Aerospace - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GE Aerospace to buy it.
The correlation of GE Aerospace is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GE Aerospace moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GE Aerospace moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GE Aerospace can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Fusion Stock
If you are still planning to invest in Fusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fusion Pharmaceuticals' history and understand the potential risks before investing.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Transaction History View history of all your transactions and understand their impact on performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |